Delirium and Cognitive Impairment Development in Hospitalized Older Adults Under Isolation Conditions

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age70+
SponsorUniversitätsklinikum Hamburg-Eppendorf

About this trial

The goal of this observational study is to examine if older patients who need to be under isolation precautions due to multidrug resistant bacteria or other reasons have an increased risk of suffering from delirium or cognitive decline compared to older patients without isolation precautions.

To compare this, every person under isolation precautions is compared to other persons of the same age, gender, comorbidities, frailty status and hospital department. Delirium is assessed twice daily with a screening tool named 3D-CAM and cognitive performance is tested by the MOCA-Test six weeks after discharge from hospital and compared to baseline values which are assessed directly after study enrollment.

The study duration for each patient participating is from the time of enrollment during hospitalization until 6 weeks after hospital discharge.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

hospitalized patients

under isolation precautions for at least 24h

70 years and above

Disqualifiers

no informed consent

intensive care treatment

life expectancy 14 days or less

Trial population

hospitalized patients of the University Medical Centre Hamburg (all departments)

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

404 Participants
are grouped into 2 trial groups
Group A: Exposition
Group B: Control

Trial outcomes

Primary outcomes

1

Delirium

Delirium screened by 3D-Confusion Assessment Method 2 times daily

Time frame
day 1-5 under isolation precautions

Secondary outcomes

1

Cognitive performance

Measures by Montreal Cognitive Assessment (MOCA). Maximum 15, minimum 0 points. Higher points indicate less functional impairment.

Time frame
at enrollment and six weeks after discharge from hospital
2

Functional state

Daily activities and functionality assessed by WHO Disability Assessment Schedule (WHODAS 2.0), a questionnaire with 36-items; answers are on a 5-step-Likert-scale; when values are summed up, higher values indicate a worse functional state

Time frame
at enrollment and six weeks after discharge from hospital
3

Quality-of-Life (QoL)

QoL assessed by WHO Quality of Life in older adults (WHO-QOL-OLD) questionnaire

Time frame
at enrollment and 6 weeks after discharge from hospital
4

Quality-of-Life (QoL)

QoL assessed by Visual Analogue Scale from EQ-5D-5L questionnaire (no abbreviation); Maximum 100 points, minimum 0 points; more points indicate a better QoL.

Time frame
at enrollment and 6 weeks after discharge from hospital

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.